Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 15 of 15 entries
Sorted by: Best Match Show Resources per page
Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL.

Blood advances

Roberts KG, Yang YL, Payne-Turner D, Lin W, Files JK, Dickerson K, Gu Z, Taunton J, Janke LJ, Chen T, Loh ML, Hunger SP, Mullighan CG.
PMID: 29296813
Blood Adv. 2017 Aug 30;1(20):1657-1671. doi: 10.1182/bloodadvances.2017011296. eCollection 2017 Sep 12.

New therapies for Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) patients are urgently needed. The genetic landscape of Ph-like ALL is characterized by a diverse array of kinase-activating alterations (including rearrangements, sequence mutations, and copy number alterations), suggesting that...

Cite
Roberts KG, Yang YL, Payne-Turner D, et al. Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL. Blood Adv. 2017;1(20):1657-1671doi: 10.1182/bloodadvances.2017011296.
Roberts, K. G., Yang, Y. L., Payne-Turner, D., Lin, W., Files, J. K., Dickerson, K., Gu, Z., Taunton, J., Janke, L. J., Chen, T., Loh, M. L., Hunger, S. P., & Mullighan, C. G. (2017). Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL. Blood advances, 1(20), 1657-1671. https://doi.org/10.1182/bloodadvances.2017011296
Roberts, Kathryn G, et al. "Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL." Blood advances vol. 1,20 (2017): 1657-1671. doi: https://doi.org/10.1182/bloodadvances.2017011296
Roberts KG, Yang YL, Payne-Turner D, Lin W, Files JK, Dickerson K, Gu Z, Taunton J, Janke LJ, Chen T, Loh ML, Hunger SP, Mullighan CG. Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL. Blood Adv. 2017 Aug 30;1(20):1657-1671. doi: 10.1182/bloodadvances.2017011296. eCollection 2017 Sep 12. PMID: 29296813; PMCID: PMC5728345.
Copy Download .nbib Format: NLM
Integrating Palliative Care in Pediatric Oncology: Evidence for an Evolving Paradigm for Comprehensive Cancer Care.

Journal of the National Comprehensive Cancer Network : JNCCN

Levine DR, Johnson LM, Snyder A, Wiser RK, Gibson D, Kane JR, Baker JN.
PMID: 27283167
J Natl Compr Canc Netw. 2016 Jun;14(6):741-8. doi: 10.6004/jnccn.2016.0076.

BACKGROUND: The demonstrated benefit of integrating palliative care (PC) into cancer treatment has triggered an increased need for PC services. The trajectory of integrating PC in comprehensive cancer centers, particularly pediatric centers, is unknown. We describe our 8-year experience...

Cite
Levine DR, Johnson LM, Snyder A, et al. Integrating Palliative Care in Pediatric Oncology: Evidence for an Evolving Paradigm for Comprehensive Cancer Care. J Natl Compr Canc Netw. 2016;14(6):741-8doi: 10.6004/jnccn.2016.0076.
Levine, D. R., Johnson, L. M., Snyder, A., Wiser, R. K., Gibson, D., Kane, J. R., & Baker, J. N. (2016). Integrating Palliative Care in Pediatric Oncology: Evidence for an Evolving Paradigm for Comprehensive Cancer Care. Journal of the National Comprehensive Cancer Network : JNCCN, 14(6), 741-8. https://doi.org/10.6004/jnccn.2016.0076
Levine, Deena R, et al. "Integrating Palliative Care in Pediatric Oncology: Evidence for an Evolving Paradigm for Comprehensive Cancer Care." Journal of the National Comprehensive Cancer Network : JNCCN vol. 14,6 (2016): 741-8. doi: https://doi.org/10.6004/jnccn.2016.0076
Levine DR, Johnson LM, Snyder A, Wiser RK, Gibson D, Kane JR, Baker JN. Integrating Palliative Care in Pediatric Oncology: Evidence for an Evolving Paradigm for Comprehensive Cancer Care. J Natl Compr Canc Netw. 2016 Jun;14(6):741-8. doi: 10.6004/jnccn.2016.0076. PMID: 27283167; PMCID: PMC5357562.
Copy Download .nbib Format: NLM
Thoughts from the threshold: patient and family hopes, fears, values, and goals at the onset of pediatric hematopoietic cell transplantation.

Bone marrow transplantation

Levine DR, Van Noy K, Talleur AC, Snyder A, Kaye EC, Baker JN.
PMID: 31992844
Bone Marrow Transplant. 2020 Jun;55(6):1103-1113. doi: 10.1038/s41409-020-0794-8. Epub 2020 Jan 28.

Hematopoietic cell transplantation (HCT) affords curative potential for high-risk patients but also carries risk of morbidity and mortality. Early palliative care (PC) integration can aid in supporting patients and families, fostering goal-directed care, and maximizing quality-of-life throughout. However, little...

Cite
Levine DR, Van Noy K, Talleur AC, et al. Thoughts from the threshold: patient and family hopes, fears, values, and goals at the onset of pediatric hematopoietic cell transplantation. Bone Marrow Transplant. 2020;55(6):1103-1113doi: 10.1038/s41409-020-0794-8.
Levine, D. R., Van Noy, K., Talleur, A. C., Snyder, A., Kaye, E. C., & Baker, J. N. (2020). Thoughts from the threshold: patient and family hopes, fears, values, and goals at the onset of pediatric hematopoietic cell transplantation. Bone marrow transplantation, 55(6), 1103-1113. https://doi.org/10.1038/s41409-020-0794-8
Levine, Deena R, et al. "Thoughts from the threshold: patient and family hopes, fears, values, and goals at the onset of pediatric hematopoietic cell transplantation." Bone marrow transplantation vol. 55,6 (2020): 1103-1113. doi: https://doi.org/10.1038/s41409-020-0794-8
Levine DR, Van Noy K, Talleur AC, Snyder A, Kaye EC, Baker JN. Thoughts from the threshold: patient and family hopes, fears, values, and goals at the onset of pediatric hematopoietic cell transplantation. Bone Marrow Transplant. 2020 Jun;55(6):1103-1113. doi: 10.1038/s41409-020-0794-8. Epub 2020 Jan 28. PMID: 31992844; PMCID: PMC8722457.
Copy Download .nbib Format: NLM
Showing 13 to 15 of 15 entries